{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:15Z","timestamp":1753891215409,"version":"3.41.2"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The global epidemic has been controlled to some extent, while sporadic outbreaks still occur in some places. It is essential to summarize the successful experience and promote the development of new drugs. This study aimed to explore the common mechanism of action of the four Chinese patent medicine (CPMs) recommended in the <jats:italic>Medical Observation Period COVID-19 Diagnostic and Treatment Protocol<\/jats:italic> and to accelerate the new drug development process. Firstly, the active ingredients and targets of the four CPMs were obtained by the Chinese medicine composition database (TCMSP, TCMID) and related literature, and the common action targets of the four TCMs were sorted out. Secondly, the targets of COVID-19 were obtained through the gene-disease database (GeneCards, NCBI). Then the Venn diagram was used to intersect the common drug targets with the disease targets. And GO and KEGG pathway functional enrichment analysis was performed on the intersected targets with the help of the R package. Finally, the results were further validated by molecular docking and molecular dynamics analysis. As a result, a total of 101 common active ingredients and 21 key active ingredients of four CPMs were obtained, including quercetin, luteolin, acacetin, kaempferol, baicalein, naringenin, artemisinin, aloe-emodin, which might be medicinal substances for the treatment of COVID-19. TNF, IL6, IL1B, CXCL8, CCL2, IL2, IL4, ICAM1, IFNG, and IL10 has been predicted as key targets. 397 GO biological functions and 166 KEGG signaling pathways were obtained. The former was mainly enriched in regulating apoptosis, inflammatory response, and T cell activation. The latter, with 92 entries related to COVID-19, was mainly enriched to signaling pathways such as Coronavirus disease\u2014COVID-19, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, and Toll-like receptor signaling pathway. Molecular docking results showed that 19\/21 of key active ingredients exhibited strong binding activity to recognized COVID-19-related targets (3CL of SARS-CoV-2, ACE2, and S protein), even better than one of these four antiviral drugs. Among them, shinflavanone had better affinity to 3CL, ACE2, and S protein of SARS-CoV-2 than these four antiviral drugs. In summary, the four CPMs may play a role in the treatment of COVID-19 by binding flavonoids such as quercetin, luteolin, and acacetin to target proteins such as ACE2, 3CLpro, and S protein and acting on TNF, IL6, IL1B, CXCL8, and other targets to participate in broad-spectrum antiviral, immunomodulatory and inflammatory responses.<\/jats:p>","DOI":"10.3389\/fmed.2022.874611","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T04:52:12Z","timestamp":1666759932000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential common mechanism of four Chinese patent medicines recommended by diagnosis and treatment protocol for COVID-19 in medical observation period"],"prefix":"10.3389","volume":"9","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingwang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baohui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/cid\/ciab494","article-title":"Outpatient treatment of severe acute respiratory syndrome coronavirus 2 infection to prevent coronavirus disease 2019 progression.","volume":"73","author":"Cohen","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (Covid-19): the epidemic and the challenges.","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of Covid-19: current state of the science.","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity."},{"key":"B4","doi-asserted-by":"publisher","first-page":"110678","DOI":"10.1016\/j.biopha.2020.110678","article-title":"Ace2, Tmprss2 distribution and extrapulmonary organ injury in patients with Covid-19.","volume":"131","author":"Dong","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00426-x","article-title":"Cd147-spike protein is a novel route for SARS-CoV-2 infection to host cells.","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"100463","DOI":"10.1016\/j.eclinm.2020.100463","article-title":"Follow-up study of the pulmonary function and related physiological characteristics of Covid-19 survivors three months after recovery.","volume":"25","author":"Zhao","year":"2020","journal-title":"EClinicalMedicine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-020-00375-1","article-title":"Reflections on treatment of Covid-19 with traditional Chinese medicine.","volume":"15","author":"Luo","year":"2020","journal-title":"Chin Med."},{"key":"B8","doi-asserted-by":"crossref","first-page":"153242","DOI":"10.1016\/j.phymed.2020.153242","article-title":"Efficacy and safety of lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial.","volume":"85","author":"Hu","year":"2021","journal-title":"Phytomedicine."},{"key":"B9","first-page":"14","article-title":"Clinical efficacy of Shufeng Jiedu capsule combined with western medicine in treatment of common Covid-19 patients by retrospective analysis.","volume":"26","author":"Ling","year":"2020","journal-title":"Chin J Exp Tradit Med Formul."},{"key":"B10","first-page":"1473","article-title":"Clinical observation on Jinhua Qinggan granule combined with conventional western medicine therapy in treating mild cases of coronavirus.","volume":"61","author":"Can","year":"2020","journal-title":"J Tradit Chin Med."},{"key":"B11","first-page":"375","article-title":"Clinical observation on 34 patients with novel coronavirus pneumonia (Covid-19) treated with intergrated traditional Chinese and Western medicine.","volume":"61","author":"Wenguang","year":"2020","journal-title":"J Tradit Chin Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fphar.2020.01066","article-title":"Chinese patent medicines in the treatment of coronavirus disease 2019 (Covid-19) in China.","volume":"11","author":"Zhuang","year":"2020","journal-title":"Front Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).","volume":"156","author":"Runfeng","year":"2020","journal-title":"Pharmacol Res."},{"key":"B14","first-page":"5","article-title":"Study on broad-spectrum antiviral effect of Shufeng Jiedu capsules.","volume":"51","author":"Yanyan","year":"2019","journal-title":"J New Chin Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"109652","DOI":"10.1016\/j.biopha.2019.109652","article-title":"Unique synergistic antiviral effects of Shufeng Jiedu capsule and oseltamivir in influenza a viral-induced acute exacerbation of chronic obstructive pulmonary disease.","volume":"121","author":"Ji","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B16","first-page":"2040","article-title":"Study on the antipyretic mechanism of Shufeng Jiedu capsules.","volume":"47","author":"Jing","year":"2016","journal-title":"Chin Tradit Herb Drugs."},{"key":"B17","first-page":"1763","article-title":"Study on mechanism for immunoregulation of Shufeng Jiedu capsule.","volume":"42","author":"Li","year":"2019","journal-title":"Drug Eval Res."},{"key":"B18","first-page":"405","article-title":"Research progress on potential application of Huoxiang Zhengqi in prevention and treatment of coronavirus disease 2019.","volume":"35","author":"Zhi-peng","year":"2020","journal-title":"Drugs Clin."},{"key":"B19","first-page":"1591","article-title":"Effect of maxing Shigan decoction against type A influenza virus infection in mice induced by viral lung injury based on Tlr4-Myd88-Traf6 signal pathways.","volume":"48","author":"Ling","year":"2017","journal-title":"Chin Tradit Herb Drugs."},{"key":"B20","first-page":"1168","article-title":"Study on screening and mechanism of effective Chinese medicine for influenza virus pneumonia.","volume":"34","author":"Ling","year":"2018","journal-title":"Chin J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ddr.21214","article-title":"Network pharmacology: a rosetta stone for traditional Chinese medicine.","volume":"75","author":"da Hao","year":"2014","journal-title":"Drug Dev Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.biopha.2018.04.054","article-title":"Network pharmacology-based identification of protective mechanism of Panax notoginseng saponins on aspirin induced gastrointestinal injury.","volume":"105","author":"Zhu","year":"2018","journal-title":"Biomed Pharmacother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.3892\/mmr.2017.7149","article-title":"Identification of the active compounds and significant pathways of Yinchenhao decoction based on network pharmacology.","volume":"16","author":"Huang","year":"2017","journal-title":"Mol Med Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jep.2013.02.004","article-title":"Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice.","volume":"146","author":"Liu","year":"2013","journal-title":"J Ethnopharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.3390\/ijms13066964","article-title":"A novel chemometric method for the prediction of human oral bioavailability.","volume":"13","author":"Xu","year":"2012","journal-title":"Int J Mol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0169-409X(02)00003-0","article-title":"Prediction of \u2018drug-likeness\u2019.","volume":"54","author":"Walters","year":"2002","journal-title":"Adv Drug Deliv Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"i246","DOI":"10.1093\/bioinformatics\/btq176","article-title":"Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.","volume":"26","author":"Yoshihiro","year":"2010","journal-title":"Bioinformatics."},{"key":"B28","first-page":"237","article-title":"Dragon software: an easy approach to molecular descriptor calculations.","volume":"56","author":"Mauri","year":"2006","journal-title":"Match."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1930598","DOI":"10.1155\/2017\/1930598","article-title":"Molecular targets and associated potential pathways of Danlu capsules in hyperplasia of mammary glands based on systems pharmacology.","volume":"2017","author":"Huang","year":"2017","journal-title":"Evid Based Complement Alternat Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1562707","DOI":"10.1155\/2019\/1562707","article-title":"A systems pharmacology approach for identifying the multiple mechanisms of action of the Wei Pi Xiao decoction for the treatment of gastric precancerous lesions.","volume":"2019","author":"Yang","year":"2019","journal-title":"Evid Based Complement Alternat Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"Jvenn: an interactive Venn diagram viewer.","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinformatics."},{"key":"B32","doi-asserted-by":"publisher","first-page":"bav028","DOI":"10.1093\/database\/bav028","article-title":"Disgenet: a discovery platform for the dynamical exploration of human diseases and their genes.","volume":"2015","author":"Pi\u00f1ero","year":"2015","journal-title":"Database."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses.","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinformatics."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1002\/cpbi.67","article-title":"Good citizenship made easy: a step\u2212by\u2212step guide to submitting Rna\u2212Seq data to Ncbi.","volume":"64","author":"Feindt","year":"2018","journal-title":"Curr Protoc Bioinformatics."},{"key":"B35","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The string database in 2017: quality-controlled protein\u2013protein association networks, made broadly accessible.","volume":"45","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"Cytohubba: identifying hub objects and sub-networks from complex interactome.","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology.","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","article-title":"Expansion of the gene ontology knowledgebase and resources.","volume":"45","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS."},{"key":"B40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbrc.2020.03.047","article-title":"Spike protein recognition of mammalian Ace2 predicts the host range and an optimized Ace2 for SARS-CoV-2 infection.","volume":"526","author":"Luan","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jinf.2020.02.026","article-title":"Covid-19 spike-host cell receptor Grp78 binding site prediction.","volume":"80","author":"Ibrahim","year":"2020","journal-title":"J Infect."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1080\/07391102.2020.1758788","article-title":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment.","volume":"39","author":"Boopathi","year":"2020","journal-title":"J Biomol Struct Dyn."},{"journal-title":"The Pymol Molecular Graphics System.","year":"2002","author":"DeLano","key":"B43"},{"key":"B44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","article-title":"Lopinavir\/Ritonavir.","volume":"63","author":"Cvetkovic","year":"2003","journal-title":"Drugs."},{"key":"B46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4254\/wjh.v8.i2.123","article-title":"Ribavirin: past, present and future.","volume":"8","author":"Loustaud-Ratti","year":"2016","journal-title":"World J Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States.","volume":"382","author":"Holshue","year":"2020","journal-title":"New Engl J Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"105472","DOI":"10.1016\/j.phrs.2021.105472","article-title":"International policies and challenges on the legalization of traditional medicine\/herbal medicines in the fight against Covid-19.","volume":"166","author":"Xiong","year":"2021","journal-title":"Pharmacol Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jconrel.2009.05.008","article-title":"Research on the pharmacodynamic material basis of compound traditional Chinese medicine and the problems that should be paid attention to in the future.","volume":"24","author":"Du","year":"2013","journal-title":"Lishizhen Med Materia Med Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fphar.2016.00201","article-title":"Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research.","volume":"7","author":"Zhou","year":"2016","journal-title":"Front Pharmacol."},{"key":"B51","first-page":"210","article-title":"Research progress on the material basis of pharmacodynamics of traditional Chinese medicine compounds.","volume":"17","author":"Yi","year":"2021","journal-title":"Asia Pac Tradit Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1073\/pnas.0712365105","article-title":"Dissection of mechanisms of Chinese medicinal formula realgar-indigo naturalis as an effective treatment for promyelocytic leukemia.","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1126\/science.319.5864.709","article-title":"Biochemistry. Lifting the veil on traditional Chinese medicine.","volume":"319","author":"Stone","year":"2008","journal-title":"Science."},{"key":"B54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00216-011-5533-y","article-title":"The herbalome\u2013an attempt to globalize Chinese herbal medicine.","volume":"402","author":"Zhang","year":"2012","journal-title":"Anal Bioanal Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pharmthera.2018.09.009","article-title":"The role of flavonoids in autoimmune diseases: therapeutic updates.","volume":"194","author":"Rengasamy","year":"2019","journal-title":"Pharmacol Therap."},{"key":"B56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phymed.2018.03.057","article-title":"Flavonoids as Th1\/Th2 cytokines immunomodulators: a systematic review of studies on animal models.","volume":"44","author":"Gandhi","year":"2018","journal-title":"Phytomedicine."},{"key":"B57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of sars-Cov 3cl protease by flavonoids.","volume":"35","author":"Jo","year":"2020","journal-title":"J Enzyme Inhibit Med Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1700031","DOI":"10.1002\/mnfr.201700031","article-title":"Quercetin protects against atherosclerosis by inhibiting dendritic cell activation.","volume":"61","author":"Lin","year":"2017","journal-title":"Mol Nutr Food Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/cbdd.13604","article-title":"Characteristics of flavonoids as potent Mers\u2212Cov 3c\u2212like protease inhibitors.","volume":"94","author":"Jo","year":"2019","journal-title":"Chem Biol Drug Design."},{"key":"B60","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s10753-015-0296-9","article-title":"The effects of quercetin on acute lung injury and biomarkers of inflammation and oxidative stress in the rat model of sepsis.","volume":"39","author":"Gerin","year":"2016","journal-title":"Inflammation."},{"key":"B61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/nu8030167","article-title":"Quercetin, inflammation and immunity.","volume":"8","author":"Li","year":"2016","journal-title":"Nutrients."},{"key":"B62","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/fcp.12315","article-title":"Quercetin reverses experimental cirrhosis by immunomodulation of the proinflammatory and profibrotic processes.","volume":"31","author":"Casas\u2212Grajales","year":"2017","journal-title":"Fundament Clin Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/jsfa.7251","article-title":"(Anti) mutagenic and immunomodulatory properties of quercetin glycosides.","volume":"96","author":"Valentov\u00e1","year":"2016","journal-title":"J Sci Food Agric."},{"key":"B64","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/jcp.10244","article-title":"Differential effects of quercetin, a natural polyphenolic flavonoid, on L\u2212type calcium current in pituitary tumor (Gh3) cells and neuronal Ng108\u221215 cells.","volume":"195","author":"Wu","year":"2003","journal-title":"J Cell Physiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1111\/j.1742-4658.2005.04888.x","article-title":"Modulatory effects of plant phenols on human multidrug\u2212resistance proteins 1, 4 and 5 (Abcc1, 4 and 5).","volume":"272","author":"Wu","year":"2005","journal-title":"FEBS J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.3390\/nu5093367","article-title":"Flavonoid bioavailability and attempts for bioavailability enhancement.","volume":"5","author":"Thilakarathna","year":"2013","journal-title":"Nutrients."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-017-0047-z","article-title":"Luteolin, quercetin, genistein and quercetagetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in H9c2 cardiomyoblasts.","volume":"22","author":"Guti\u00e9rrez-Venegas","year":"2017","journal-title":"Cell Mol Biol Lett."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jfma.2016.08.009","article-title":"Chemotherapeutic effects of luteolin on radio-sensitivity enhancement and interleukin-6\/signal transducer and activator of transcription 3 signaling repression of oral cancer stem cells.","volume":"115","author":"Tu","year":"2016","journal-title":"J Formos Med Assoc."},{"key":"B69","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jep.2017.04.022","article-title":"Antioxidant and Anti-inflammatory activities of the major phenolics from Zygophyllum simplex L.","volume":"205","author":"Abdallah","year":"2017","journal-title":"J Ethnopharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1017\/S0967199419000674","article-title":"Supplementation of kaempferol to in vitro maturation medium regulates oxidative stress and enhances subsequent embryonic development in vitro.","volume":"28","author":"Zhao","year":"2020","journal-title":"Zygote."},{"key":"B71","first-page":"463","article-title":"In vitro anti-Hiv-1 activities of kaempferol and kaempferol-7-o-glucoside isolated from Securigera securidaca.","volume":"9","author":"Behbahani","year":"2014","journal-title":"Res Pharm Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/01635581.2015.976320","article-title":"Chemopreventive and therapeutic potential of \u201cnaringenin,\u201d a flavanone present in citrus fruits.","volume":"67","author":"Mir","year":"2015","journal-title":"Nutr Cancer."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/BF02978215","article-title":"Antiherpetic activities of flavonoids against herpes simplex virus type 1 (Hsv-1) and type 2 (Hsv-2) in vitro.","volume":"28","author":"Lyu","year":"2005","journal-title":"Arch Pharm Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1016\/j.bmc.2008.06.049","article-title":"Structure\u2013activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.","volume":"16","author":"Liu","year":"2008","journal-title":"Bioorg Med Chem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.antiviral.2005.08.002","article-title":"Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action.","volume":"68","author":"Evers","year":"2005","journal-title":"Antiviral Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/ijms18102043","article-title":"Licochalcone a prevents the loss of dopaminergic neurons by inhibiting microglial activation in lipopolysaccharide (Lps)-induced Parkinson\u2019s disease models.","volume":"18","author":"Huang","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/ijms18071500","article-title":"Licochalcone a prevents platelet activation and thrombus formation through the inhibition of Plc\u03b32-Pkc, Akt, and Mapk pathways.","volume":"18","author":"Lien","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of Sars-associated coronavirus.","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet."},{"key":"B79","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10787-017-0398-0","article-title":"Acacetin attenuates mice endotoxin-induced acute lung injury via augmentation of heme oxygenase-1 activity.","volume":"26","author":"Wu","year":"2018","journal-title":"Inflammopharmacology."},{"key":"B80","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4149\/av_2018_109","article-title":"Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of Ampk pathways.","volume":"62","author":"Seong","year":"2018","journal-title":"Acta Virol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.antiviral.2011.07.008","article-title":"Synergistic activity of baicalein with ribavirin against influenza a (H1n1) virus infections in cell culture and in mice.","volume":"91","author":"Chen","year":"2011","journal-title":"Antiviral Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fphar.2017.00589","article-title":"Acacetin from traditionally used saussurea involucrata Kar. Et Kir. Suppressed adipogenesis in 3t3-L1 adipocytes and attenuated lipid accumulation in obese mice.","volume":"8","author":"Liou","year":"2017","journal-title":"Front Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"9310","DOI":"10.18632\/aging.102371","article-title":"Baicalein attenuates ova-induced allergic airway inflammation through the inhibition of the Nf-K b signaling pathway.","volume":"11","author":"Xu","year":"2019","journal-title":"Aging."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1159\/000366343","article-title":"Acacetin blocks Kv1. 3 channels and inhibits human T cell activation.","volume":"34","author":"Zhao","year":"2014","journal-title":"Cell Physiol Biochem."},{"key":"B85","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acsinfecdis.0c00522","article-title":"Anti-SARS-CoV-2 potential of artemisinins in vitro.","volume":"6","author":"Cao","year":"2020","journal-title":"ACS Infect Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-93361-y","article-title":"In vitro efficacy of artemisinin-based treatments against SARS-CoV-2.","volume":"11","author":"Gilmore","year":"2020","journal-title":"Sci Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"106216","DOI":"10.1016\/j.ijantimicag.2020.106216","article-title":"Safety and efficacy of artemisinin-piperaquine for treatment of Covid-19: an open-label, non-randomised and controlled trial.","volume":"57","author":"Li","year":"2021","journal-title":"Int J Antimicrob Agents."},{"key":"B88","first-page":"417","article-title":"Clinical study of artesunate in the treatment of coronavirus disease 2019.","volume":"32","author":"Lin","year":"2020","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue."},{"key":"B89","doi-asserted-by":"publisher","first-page":"649532","DOI":"10.3389\/fphar.2021.649532","article-title":"Repurposing anti-malaria phytomedicine artemisinin as a Covid-19 drug.","volume":"12","author":"Uckun","year":"2021","journal-title":"Front Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"338","DOI":"10.26502\/ijabpt.202104","article-title":"Anthraquinones: a promising multi-target therapeutic scaffold to treat Covid-19.","volume":"12","author":"El Mazouri","year":"2021","journal-title":"Int J Appl Biol Pharm Technol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s12272-013-0325-x","article-title":"Antiviral activity of rheum palmatum methanol extract and chrysophanol against Japanese encephalitis virus.","volume":"37","author":"Chang","year":"2014","journal-title":"Arch Pharm Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","article-title":"Anti-Sars coronavirus 3c-like protease effects of isatis indigotica root and plant-derived phenolic compounds.","volume":"68","author":"Lin","year":"2005","journal-title":"Antiviral Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.1080\/07391102.2020.1804457","article-title":"In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of Covid-19: an approach to prevent virus assembly.","volume":"39","author":"Rolta","year":"2021","journal-title":"J Biomol Struct Dyn."},{"key":"B94","first-page":"166","article-title":"In silico identification of potent FDA approved drugs against coronavirus Covid-19 main protease: a drug repurposing approach.","volume":"7","author":"Kumar","year":"2020","journal-title":"Chem Biol Lett."},{"key":"B95","doi-asserted-by":"publisher","first-page":"112517","DOI":"10.1016\/j.biopha.2021.112517","article-title":"Rdrp inhibitors and Covid-19: is molnupiravir a good option?","volume":"146","author":"Hashemian","year":"2022","journal-title":"Biomed Pharmacother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1080\/07391102.2020.1757510","article-title":"Peptide-like and small-molecule inhibitors against Covid-19.","volume":"39","author":"Pant","year":"2021","journal-title":"J Biomol Struct Dyn."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acsinfecdis.1c00070","article-title":"Small-molecule inhibitors of the coronavirus spike: ace2 protein-protein interaction as blockers of viral attachment and entry for SARS-CoV-2.","volume":"7","author":"Bojadzic","year":"2021","journal-title":"ACS Infect Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1111\/febs.15696","article-title":"Overview of antiviral drug candidates targeting coronaviral 3c-like main proteases.","volume":"288","author":"Chen","year":"2021","journal-title":"FEBS J."},{"key":"B99","first-page":"100","article-title":"Screening efficacy of available HIV protease inhibitors on Covid-19 protease.","volume":"22","author":"Mirzaei","year":"2020","journal-title":"J Mil Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"113201","DOI":"10.1016\/j.ejmech.2021.113201","article-title":"RNA-dependent RNA polymerase (Rdrp) inhibitors: the current landscape and repurposing for the Covid-19 pandemic.","volume":"213","author":"Tian","year":"2021","journal-title":"Eur J Med Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"107587","DOI":"10.1016\/j.pharmthera.2020.107587","article-title":"Cathepsin L-selective inhibitors: a potentially promising treatment for Covid-19 patients.","volume":"213","author":"Liu","year":"2020","journal-title":"Pharmacol Ther."},{"key":"B102","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-0369-9","article-title":"Reply to: \u2018Interaction between Raas inhibitors and Ace2 in the context of Covid-19\u2019.","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B103","first-page":"219","article-title":"[Inhibitors of Ras might be a good choice for the therapy of Covid-19 pneumonia].","volume":"43","author":"Sun","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi."},{"key":"B104","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/s41375-021-01266-6","article-title":"Jak-inhibitors for coronavirus disease-2019 (Covid-19): a meta-analysis.","volume":"35","author":"Chen","year":"2021","journal-title":"Leukemia."},{"key":"B105","doi-asserted-by":"publisher","first-page":"05005","DOI":"10.7189\/jogh.12.05005","article-title":"Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with Covid-19.","volume":"12","author":"Wu","year":"2022","journal-title":"J Glob Health."},{"key":"B106","doi-asserted-by":"publisher","first-page":"13205","DOI":"10.1021\/acs.jmedchem.0c00626","article-title":"Chinese therapeutic strategy for fighting Covid-19 and potential small-molecule inhibitors against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","volume":"63","author":"Choudhry","year":"2020","journal-title":"J Med Chem."},{"key":"B107","first-page":"1591","article-title":"Effect of maxing shigan decoction against type A influenza virus infection in mice induced by viral lung injury based on Tlr4-Myd88-Traf6 signal pathways.","volume":"48","author":"Li","year":"2017","journal-title":"Chin Tradit Herb Drugs."},{"key":"B108","first-page":"1664","article-title":"Clinical efficacy of different doses of Jinhuaqinggan granule on influenza and serum levels of cytokines.","volume":"44","author":"Qi","year":"2016","journal-title":"Mod Med."},{"key":"B109","first-page":"18","article-title":"Network-based pharmacology and bioinformatics study on the potential targets and mechanisms of \u201cJinhua Qingsense granules\u201d in the treatment of novel coronavirus pneumonia.","volume":"48","author":"Xia","year":"2021","journal-title":"Liaoning J Tradit Chin Med."},{"key":"B110","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1360\/TB-2022-0375","article-title":"Clinical and pharmacological advances in the treatment of Covid-19 with the \u201cthree-drug triad\u201d.","volume":"67","author":"Gao","year":"2022","journal-title":"Chin Sci Bull."},{"key":"B111","first-page":"2070","article-title":"Study on network pharmacology of Jinhua Qinggan granules in the treatment of novel coronavirus pneumonia.","volume":"43","author":"Lin","year":"2020","journal-title":"J Chin Med Mater."},{"key":"B112","first-page":"2842","article-title":"Exploring the mechanism of action of Jinhua Qingxiang granules in the treatment of novel coronavirus pneumonia.","volume":"43","author":"Mao","year":"2020","journal-title":"J Chin Med Mater."},{"key":"B113","first-page":"1188","article-title":"Exploring the anti-influenza virus mechanism of Ma Heng Shi Gan Tang based on Tlr7\/8-mediated Ifn-A\/B protein expression levels of ephedra first decoction.","volume":"34","author":"Zhang","year":"2019","journal-title":"China J Tradit Chin Med Pharm."},{"key":"B114","first-page":"213","article-title":"Effects of silver forsythia on Jak\/Stat signaling pathway and expression of Ns1 protein and Mx a protein in lung tissue of mice with Fm1-induced pneumonia.","volume":"23","author":"Wang","year":"2020","journal-title":"China Pharmacist."},{"key":"B115","first-page":"645","article-title":"A preliminary investigation on the effective components and mechanism of Huo Xiang Zheng Qi tang to inhibit the replication process of novel coronavirus.","volume":"22","author":"Du","year":"2020","journal-title":"Modern Tradit Chin Med Materia Med World Sci Technol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"111310","DOI":"10.1016\/j.biopha.2021.111310","article-title":"Research progress of traditional Chinese medicine against Covid-19.","volume":"137","author":"Ren","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B117","first-page":"1113","article-title":"Study on active compounds from Huoxiang Zhengqi oral liquid for prevention of coronavirus disease 2019 (Covid-19) based on network pharmacology and molecular docking.","volume":"51","author":"Deng","year":"2020","journal-title":"Chin Tradit Herb Drugs."},{"key":"B118","first-page":"1113","article-title":"Exploration of active compounds of Huoxiang Zhengqi oral liquid for the prevention of novel coronavirus pneumonia (Covid-19) based on network pharmacology and molecular docking method.","volume":"51","author":"Deng","year":"2020","journal-title":"Chin Tradit Herb Drugs."},{"key":"B119","first-page":"115","article-title":"Exploring the possible mechanism of action of sparse wind relief capsules for the treatment of novel coronavirus pneumonia based on network pharmacology and molecular docking.","volume":"18","author":"Liu","year":"2021","journal-title":"Chin J Pharmacovigilance."},{"key":"B120","first-page":"3080","article-title":"A network pharmacological study on the treatment of novel coronavirus pneumonia with Shu Feng Jie toxin capsule.","volume":"43","author":"Li","year":"2020","journal-title":"J Chin Med Mater."},{"key":"B121","first-page":"2040","article-title":"Study on the mechanism of antipyretic effect of Shu Feng Jie toxin capsule.","volume":"47","author":"Liu","year":"2016","journal-title":"Chin Tradit Herb Drugs."},{"key":"B122","first-page":"1763","article-title":"Study on the mechanism of immunomodulatory effect of Shu Feng Jie toxin capsule.","volume":"42","author":"Ma","year":"2019","journal-title":"Drug Eval Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/s0955-2863(03)00032-9","article-title":"Common gene polymorphisms and nutrition: emerging links with pathogenesis of multifactorial chronic diseases (review).","volume":"14","author":"Loktionov","year":"2003","journal-title":"J Nutr Biochem."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.2174\/156802612801319034","article-title":"Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine.","volume":"12","author":"Wang","year":"2012","journal-title":"Curr Top Med Chem."},{"key":"B125","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-Ncov: host-directed therapies should be an option.","volume":"395","author":"Zumla","year":"2020","journal-title":"Lancet."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.874611\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T04:52:51Z","timestamp":1666759971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.874611\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":126,"alternative-id":["10.3389\/fmed.2022.874611"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.874611","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"article-number":"874611"}}